Insider Trading disclosures for Lexicon Pharma Inc

The latest disclosure was made by Raymond Debbane in Lexicon Pharma Inc where a trade of 35,714 Restricted Stock Units done was reported to US exchanges on May 1, 2026.

Insider trading is the trading of a company’s securities by individuals with access to confidential or material non-public information about the company. A company is required to report trading by corporate officers, directors, or other company members with significant access to privileged information to the Securities and Exchange Commission (SEC).

Client Name	Client Category	Action	Reported to Exchange	Quantity	Post Transaction Holding	Traded %	Avg. Price	Value	Security Type
Raymond Debbane	Director	Grant, award, or other acquisition of securities at price $ 0.00 per share.	01 May 2026	35,714	35,714	-		-	Restricted Stock Units
Raymond Debbane	Director	Grant, award, or other acquisition of securities at price $ 0.00 per share.	01 May 2026	43,478	43,478	-		-	Stock Option (Right to Buy)
Brian T. Crum	SVP, General Counsel & Secr.	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	28 Feb 2026	33,457	363,658 (0%)	0%		-	Common Stock
Brian T. Crum	SVP, General Counsel & Secr.	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	28 Feb 2026	170,163	340,327	-		-	Restricted Stock Units
Brian T. Crum	SVP, General Counsel & Secr.	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	28 Feb 2026	33,457	0	-		-	Restricted Stock Units
Brian T. Crum	SVP, General Counsel & Secr.	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	28 Feb 2026	69,386	69,387	-		-	Restricted Stock Units
Brian T. Crum	SVP, General Counsel & Secr.	Payment of exercise price or tax liability using portion of securities received from the company at price $ 1.47 per share.	28 Feb 2026	105,019	428,802 (0%)	0%	1.5	154,378	Common Stock
Brian T. Crum	SVP, General Counsel & Secr.	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	28 Feb 2026	170,163	533,821 (0%)	0%		-	Common Stock
Brian T. Crum	SVP, General Counsel & Secr.	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	28 Feb 2026	69,386	330,201 (0%)	0%		-	Common Stock
Scott M. Coiante	SVP, Chief Financial Officer	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	28 Feb 2026	160,237	160,237 (0%)	0%		-	Common Stock
Scott M. Coiante	SVP, Chief Financial Officer	Payment of exercise price or tax liability using portion of securities received from the company at price $ 1.47 per share.	28 Feb 2026	54,881	105,356 (0%)	0%	1.5	80,675	Common Stock
Scott M. Coiante	SVP, Chief Financial Officer	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	28 Feb 2026	160,237	320,473	-		-	Restricted Stock Units
Lisa DeFrancesco	SVP, IR and Corp Comm	Payment of exercise price or tax liability using portion of securities received from the company at price $ 1.47 per share.	28 Feb 2026	74,572	93,869 (0%)	0%	1.5	109,621	Common Stock
Lisa DeFrancesco	SVP, IR and Corp Comm	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	28 Feb 2026	24,674	24,673	-		-	Restricted Stock Units
Lisa DeFrancesco	SVP, IR and Corp Comm	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	28 Feb 2026	24,674	40,251 (0%)	0%		-	Common Stock
Lisa DeFrancesco	SVP, IR and Corp Comm	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	28 Feb 2026	128,190	168,441 (0%)	0%		-	Common Stock
Lisa DeFrancesco	SVP, IR and Corp Comm	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	28 Feb 2026	128,190	256,380	-		-	Restricted Stock Units
Craig B. Granowitz	SVP, Chief Medical Officer	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	28 Feb 2026	74,226	74,227	-		-	Restricted Stock Units
Craig B. Granowitz	SVP, Chief Medical Officer	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	28 Feb 2026	35,790	0	-		-	Restricted Stock Units
Craig B. Granowitz	SVP, Chief Medical Officer	Payment of exercise price or tax liability using portion of securities received from the company at price $ 1.47 per share.	28 Feb 2026	109,098	323,430 (0%)	0%	1.5	160,374	Common Stock
Craig B. Granowitz	SVP, Chief Medical Officer	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	28 Feb 2026	202,260	432,528 (0%)	0%		-	Common Stock
Craig B. Granowitz	SVP, Chief Medical Officer	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	28 Feb 2026	74,226	230,268 (0%)	0%		-	Common Stock
Craig B. Granowitz	SVP, Chief Medical Officer	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	28 Feb 2026	35,790	156,042 (0%)	0%		-	Common Stock
Craig B. Granowitz	SVP, Chief Medical Officer	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	28 Feb 2026	202,260	404,520	-		-	Restricted Stock Units
Wendy E. McDermott	SVP, Human Resources	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	28 Feb 2026	52,316	201,659 (0%)	0%		-	Common Stock
Wendy E. McDermott	SVP, Human Resources	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	28 Feb 2026	144,393	288,787	-		-	Restricted Stock Units
Wendy E. McDermott	SVP, Human Resources	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	28 Feb 2026	52,316	52,317	-		-	Restricted Stock Units
Wendy E. McDermott	SVP, Human Resources	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	28 Feb 2026	27,697	0	-		-	Restricted Stock Units
Wendy E. McDermott	SVP, Human Resources	Payment of exercise price or tax liability using portion of securities received from the company at price $ 1.47 per share.	28 Feb 2026	68,107	277,945 (0%)	0%	1.5	100,117	Common Stock
Wendy E. McDermott	SVP, Human Resources	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	28 Feb 2026	144,393	346,052 (0%)	0%		-	Common Stock
Wendy E. McDermott	SVP, Human Resources	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	28 Feb 2026	27,697	149,343 (0%)	0%		-	Common Stock
Michael Exton	Director, Chief Executive Officer	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	28 Feb 2026	503,263	503,263 (0%)	0%		-	Common Stock
Michael Exton	Director, Chief Executive Officer	Payment of exercise price or tax liability using portion of securities received from the company at price $ 1.47 per share.	28 Feb 2026	204,831	298,432 (0%)	0%	1.5	301,102	Common Stock
Michael Exton	Director, Chief Executive Officer	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	28 Feb 2026	503,263	1,006,527	-		-	Restricted Stock Units
Rachel Yap Martens	SVP, Partnerships & Corp Strat	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	28 Feb 2026	67,090	67,090 (0%)	0%		-	Common Stock
Rachel Yap Martens	SVP, Partnerships & Corp Strat	Payment of exercise price or tax liability using portion of securities received from the company at price $ 1.47 per share.	28 Feb 2026	35,826	31,264 (0%)	0%	1.5	52,664	Common Stock
Rachel Yap Martens	SVP, Partnerships & Corp Strat	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	28 Feb 2026	67,090	134,180	-		-	Restricted Stock Units
Suma Gopinathan	SVP, Discovery	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	28 Feb 2026	14,000	0	-		-	Restricted Stock Units
Suma Gopinathan	SVP, Discovery	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	28 Feb 2026	14,000	88,520 (0%)	0%		-	Common Stock
Suma Gopinathan	SVP, Discovery	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	28 Feb 2026	20,310	108,830 (0%)	0%		-	Common Stock
Suma Gopinathan	SVP, Discovery	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	28 Feb 2026	65,640	174,470 (0%)	0%		-	Common Stock
Suma Gopinathan	SVP, Discovery	Payment of exercise price or tax liability using portion of securities received from the company at price $ 1.47 per share.	28 Feb 2026	24,338	150,132 (0%)	0%	1.5	35,777	Common Stock
Suma Gopinathan	SVP, Discovery	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	28 Feb 2026	20,310	20,310	-		-	Restricted Stock Units
Suma Gopinathan	SVP, Discovery	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	28 Feb 2026	65,640	131,280	-		-	Restricted Stock Units
Raymond Debbane	Director	Purchase of securities on an exchange or from another person at price $ 1.49 per share.	25 Feb 2026	2,000	1,906,186 (1%)	0%	1.5	2,980	Common Stock
Raymond Debbane	Director	Purchase of securities on an exchange or from another person at price $ 1.47 per share.	23 Feb 2026	100,000	1,904,186 (1%)	0%	1.5	147,000	Common Stock
Raymond Debbane	Director	Purchase of securities on an exchange or from another person at price $ 1.48 per share.	19 Feb 2026	100,000	1,804,186 (1%)	0%	1.5	147,790	Common Stock
Raymond Debbane	Director	Purchase of securities on an exchange or from another person at price $ 1.44 per share.	19 Feb 2026	50,000	1,704,186 (1%)	0%	1.4	71,965	Common Stock
Raymond Debbane	Director	Purchase of securities on an exchange or from another person at price $ 1.31 per share.	13 Feb 2026	57,952	1,443,641 (1%)	0%	1.3	75,877	Common Stock
Raymond Debbane	Director	Purchase of securities on an exchange or from another person at price $ 1.32 per share.	13 Feb 2026	133,688	1,654,186 (1%)	0%	1.3	176,468	Common Stock
Raymond Debbane	Director	Purchase of securities on an exchange or from another person at price $ 1.31 per share.	13 Feb 2026	76,857	1,520,498 (1%)	0%	1.3	100,544	Common Stock
Brian T. Crum	SVP, General Counsel & Secr.	Grant, award, or other acquisition of securities at price $ 0.00 per share.	12 Feb 2026	449,560	449,560	-		-	Stock Option (Right to Buy)
Brian T. Crum	SVP, General Counsel & Secr.	Grant, award, or other acquisition of securities at price $ 0.00 per share.	12 Feb 2026	299,710	299,710	-		-	Restricted Stock Units
Scott M. Coiante	SVP, Chief Financial Officer	Grant, award, or other acquisition of securities at price $ 0.00 per share.	12 Feb 2026	272,680	272,680	-		-	Restricted Stock Units
Scott M. Coiante	SVP, Chief Financial Officer	Grant, award, or other acquisition of securities at price $ 0.00 per share.	12 Feb 2026	409,020	409,020	-		-	Stock Option (Right to Buy)
Lisa DeFrancesco	SVP, IR and Corp Comm	Grant, award, or other acquisition of securities at price $ 0.00 per share.	12 Feb 2026	386,300	386,300	-		-	Stock Option (Right to Buy)
Lisa DeFrancesco	SVP, IR and Corp Comm	Grant, award, or other acquisition of securities at price $ 0.00 per share.	12 Feb 2026	257,530	257,530	-		-	Restricted Stock Units
Craig B. Granowitz	SVP, Chief Medical Officer	Grant, award, or other acquisition of securities at price $ 0.00 per share.	12 Feb 2026	346,610	346,610	-		-	Restricted Stock Units
Craig B. Granowitz	SVP, Chief Medical Officer	Grant, award, or other acquisition of securities at price $ 0.00 per share.	12 Feb 2026	519,920	519,920	-		-	Stock Option (Right to Buy)
Wendy E. McDermott	SVP, Human Resources	Grant, award, or other acquisition of securities at price $ 0.00 per share.	12 Feb 2026	250,200	250,200	-		-	Restricted Stock Units
Wendy E. McDermott	SVP, Human Resources	Grant, award, or other acquisition of securities at price $ 0.00 per share.	12 Feb 2026	375,300	375,300	-		-	Stock Option (Right to Buy)
Michael Exton	Director, Chief Executive Officer	Grant, award, or other acquisition of securities at price $ 0.00 per share.	12 Feb 2026	862,440	862,440	-		-	Restricted Stock Units
Michael Exton	Director, Chief Executive Officer	Grant, award, or other acquisition of securities at price $ 0.00 per share.	12 Feb 2026	1,293,670	1,293,670	-		-	Stock Option (Right to Buy)
Rachel Yap Martens	SVP, Partnerships & Corp Strat	Grant, award, or other acquisition of securities at price $ 0.00 per share.	12 Feb 2026	193,740	193,740	-		-	Restricted Stock Units
Rachel Yap Martens	SVP, Partnerships & Corp Strat	Grant, award, or other acquisition of securities at price $ 0.00 per share.	12 Feb 2026	290,620	290,620	-		-	Stock Option (Right to Buy)
Suma Gopinathan	SVP, Discovery	Grant, award, or other acquisition of securities at price $ 0.00 per share.	12 Feb 2026	357,680	357,680	-		-	Stock Option (Right to Buy)
Suma Gopinathan	SVP, Discovery	Grant, award, or other acquisition of securities at price $ 0.00 per share.	12 Feb 2026	238,450	238,450	-		-	Restricted Stock Units
Raymond Debbane	Director	Grant, award, or other acquisition of securities at price $ 0.00 per share.	03 Jun 2025	89,312	89,312	-		-	Restricted Stock Units
Raymond Debbane	Director	Grant, award, or other acquisition of securities at price $ 0.00 per share.	03 Jun 2025	103,806	103,806	-		-	Stock Option (Right to Buy)
Samuel L. Barker	Director	Grant, award, or other acquisition of securities at price $ 0.00 per share.	03 Jun 2025	103,806	103,806	-		-	Stock Option (Right to Buy)
Samuel L. Barker	Director	Grant, award, or other acquisition of securities at price $ 0.00 per share.	03 Jun 2025	89,312	89,312	-		-	Restricted Stock Units
Christopher J. Sobecki	Director	Grant, award, or other acquisition of securities at price $ 0.00 per share.	03 Jun 2025	89,312	89,312	-		-	Restricted Stock Units
Christopher J. Sobecki	Director	Grant, award, or other acquisition of securities at price $ 0.00 per share.	03 Jun 2025	103,806	103,806	-		-	Stock Option (Right to Buy)
Philippe J. Amouyal	Director	Grant, award, or other acquisition of securities at price $ 0.00 per share.	03 Jun 2025	89,312	89,312	-		-	Restricted Stock Units
Philippe J. Amouyal	Director	Grant, award, or other acquisition of securities at price $ 0.00 per share.	03 Jun 2025	103,806	103,806	-		-	Stock Option (Right to Buy)
Judith L. Swain	Director	Grant, award, or other acquisition of securities at price $ 0.00 per share.	03 Jun 2025	89,312	89,312	-		-	Restricted Stock Units
Judith L. Swain	Director	Grant, award, or other acquisition of securities at price $ 0.00 per share.	03 Jun 2025	103,806	103,806	-		-	Stock Option (Right to Buy)
Diane E. Sullivan	Director	Grant, award, or other acquisition of securities at price $ 0.00 per share.	03 Jun 2025	89,312	89,312	-		-	Restricted Stock Units
Diane E. Sullivan	Director	Grant, award, or other acquisition of securities at price $ 0.00 per share.	03 Jun 2025	103,806	103,806	-		-	Stock Option (Right to Buy)
Ivan H. Cheung	Director	Grant, award, or other acquisition of securities at price $ 0.00 per share.	03 Jun 2025	89,312	89,312	-		-	Restricted Stock Units
Ivan H. Cheung	Director	Grant, award, or other acquisition of securities at price $ 0.00 per share.	03 Jun 2025	103,806	103,806	-		-	Stock Option (Right to Buy)
Raymond Debbane	Director	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	13 May 2025	36,810	0	-		-	Restricted Stock Units
Raymond Debbane	Director	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	13 May 2025	36,810	1,385,689 (1%)	0%		0	Common Stock
Samuel L. Barker	Director	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	13 May 2025	36,810	0	-		-	Restricted Stock Units
Samuel L. Barker	Director	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	13 May 2025	36,810	124,459 (0%)	0%		0	Common Stock
Christopher J. Sobecki	Director	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	13 May 2025	36,810	0	-		-	Restricted Stock Units
Christopher J. Sobecki	Director	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	13 May 2025	36,810	203,865 (0%)	0%		0	Common Stock
Philippe J. Amouyal	Director	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	13 May 2025	36,810	0	-		-	Restricted Stock Units
Philippe J. Amouyal	Director	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	13 May 2025	36,810	285,174 (0%)	0%		0	Common Stock
Judith L. Swain	Director	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	13 May 2025	36,810	0	-		-	Restricted Stock Units
Judith L. Swain	Director	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	13 May 2025	36,810	85,174 (0%)	0%		0	Common Stock
Diane E. Sullivan	Director	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	13 May 2025	36,810	0	-		-	Restricted Stock Units
Diane E. Sullivan	Director	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	13 May 2025	36,810	36,810 (0%)	0%		0	Common Stock
Alan J. Main	EVP, Innov & Chem Sciences		28 Feb 2025	68,243	136,487	-		-	Restricted Stock Units
Alan J. Main	EVP, Innov & Chem Sciences		28 Feb 2025	25,667	281,391 (0%)	0%		-	Common Stock
Alan J. Main	EVP, Innov & Chem Sciences		28 Feb 2025	32,904	314,295 (0%)	0%		-	Common Stock
Alan J. Main	EVP, Innov & Chem Sciences		28 Feb 2025	68,243	382,538 (0%)	0%		-	Common Stock
Alan J. Main	EVP, Innov & Chem Sciences		28 Feb 2025	43,434	339,104 (0%)	0%	0.7	29,101	Common Stock
Alan J. Main	EVP, Innov & Chem Sciences		28 Feb 2025	25,667	0	-		-	Restricted Stock Units
Alan J. Main	EVP, Innov & Chem Sciences		28 Feb 2025	32,904	32,903	-		-	Restricted Stock Units
Brian T. Crum	SVP, General Counsel & Secr.	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	28 Feb 2025	69,387	306,437 (0%)	0%		-	Common Stock
Brian T. Crum	SVP, General Counsel & Secr.	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	28 Feb 2025	69,387	138,773	-		-	Restricted Stock Units
Brian T. Crum	SVP, General Counsel & Secr.	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	28 Feb 2025	33,456	33,457	-		-	Restricted Stock Units
Brian T. Crum	SVP, General Counsel & Secr.	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	28 Feb 2025	26,097	0	-		-	Restricted Stock Units
Brian T. Crum	SVP, General Counsel & Secr.	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	28 Feb 2025	26,097	203,594 (0%)	0%		-	Common Stock
Brian T. Crum	SVP, General Counsel & Secr.	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	28 Feb 2025	33,456	237,050 (0%)	0%		-	Common Stock
Brian T. Crum	SVP, General Counsel & Secr.	Payment of exercise price or tax liability using portion of securities received from the company at price $ 0.67 per share.	28 Feb 2025	45,622	260,815 (0%)	0%	0.7	30,567	Common Stock
Kristen L. Alexander	VP, Finance and Accounting	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	28 Feb 2025	19,887	39,773	-		-	Restricted Stock Units
Kristen L. Alexander	VP, Finance and Accounting	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	28 Feb 2025	10,617	58,417 (0%)	0%		-	Common Stock
Kristen L. Alexander	VP, Finance and Accounting	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	28 Feb 2025	15,926	74,343 (0%)	0%		-	Common Stock
Kristen L. Alexander	VP, Finance and Accounting	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	28 Feb 2025	19,887	94,230 (0%)	0%		-	Common Stock
Kristen L. Alexander	VP, Finance and Accounting	Payment of exercise price or tax liability using portion of securities received from the company at price $ 0.67 per share.	28 Feb 2025	17,862	76,368 (0%)	0%	0.7	11,968	Common Stock
Kristen L. Alexander	VP, Finance and Accounting	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	28 Feb 2025	10,617	0	-		-	Restricted Stock Units
Kristen L. Alexander	VP, Finance and Accounting	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	28 Feb 2025	15,926	15,927	-		-	Restricted Stock Units
Craig B. Granowitz	SVP, Chief Medical Officer	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	28 Feb 2025	74,227	148,453	-		-	Restricted Stock Units
Craig B. Granowitz	SVP, Chief Medical Officer	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	28 Feb 2025	27,917	75,543 (0%)	0%		-	Common Stock
Craig B. Granowitz	SVP, Chief Medical Officer	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	28 Feb 2025	35,790	111,333 (0%)	0%		-	Common Stock
Craig B. Granowitz	SVP, Chief Medical Officer	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	28 Feb 2025	74,227	185,560 (0%)	0%		-	Common Stock
Craig B. Granowitz	SVP, Chief Medical Officer	Payment of exercise price or tax liability using portion of securities received from the company at price $ 0.67 per share.	28 Feb 2025	65,308	120,252 (0%)	0%	0.7	43,756	Common Stock
Craig B. Granowitz	SVP, Chief Medical Officer	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	28 Feb 2025	27,917	0	-		-	Restricted Stock Units
Craig B. Granowitz	SVP, Chief Medical Officer	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	28 Feb 2025	35,790	35,790	-		-	Restricted Stock Units
Wendy E. McDermott	SVP, Human Resources	Payment of exercise price or tax liability using portion of securities received from the company at price $ 0.67 per share.	28 Feb 2025	30,004	121,646 (0%)	0%	0.7	20,103	Common Stock
Wendy E. McDermott	SVP, Human Resources	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	28 Feb 2025	18,943	0	-		-	Restricted Stock Units
Wendy E. McDermott	SVP, Human Resources	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	28 Feb 2025	27,696	27,697	-		-	Restricted Stock Units
Wendy E. McDermott	SVP, Human Resources	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	28 Feb 2025	52,317	104,633	-		-	Restricted Stock Units
Wendy E. McDermott	SVP, Human Resources	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	28 Feb 2025	18,943	71,637 (0%)	0%		-	Common Stock
Wendy E. McDermott	SVP, Human Resources	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	28 Feb 2025	27,696	99,333 (0%)	0%		-	Common Stock
Wendy E. McDermott	SVP, Human Resources	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	28 Feb 2025	52,317	151,650 (0%)	0%		-	Common Stock
Lisa DeFrancesco	SVP, IR and Corp Comm	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	28 Feb 2025	24,673	49,347	-		-	Restricted Stock Units
Lisa DeFrancesco	SVP, IR and Corp Comm	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	28 Feb 2025	24,673	24,673 (0%)	0%		-	Common Stock
Lisa DeFrancesco	SVP, IR and Corp Comm	Payment of exercise price or tax liability using portion of securities received from the company at price $ 0.67 per share.	28 Feb 2025	9,096	15,577 (0%)	0%	0.7	6,094	Common Stock
Alan J. Main	EVP, Innov & Chem Sciences		13 Feb 2025	502,060	502,060	-		-	Restricted Stock Units
Alan J. Main	EVP, Innov & Chem Sciences		13 Feb 2025	753,090	753,090	-		-	Stock Option (Right to Buy)
Brian T. Crum	SVP, General Counsel & Secr.	Grant, award, or other acquisition of securities at price $ 0.00 per share.	13 Feb 2025	765,730	765,730	-		-	Stock Option (Right to Buy)
Brian T. Crum	SVP, General Counsel & Secr.	Grant, award, or other acquisition of securities at price $ 0.00 per share.	13 Feb 2025	510,490	510,490	-		-	Restricted Stock Units
Scott M. Coiante	SVP, Chief Financial Officer	Grant, award, or other acquisition of securities at price $ 0.00 per share.	13 Feb 2025	480,710	480,710	-		-	Restricted Stock Units
Scott M. Coiante	SVP, Chief Financial Officer	Grant, award, or other acquisition of securities at price $ 0.00 per share.	13 Feb 2025	721,070	721,070	-		-	Stock Option (Right to Buy)
Kristen L. Alexander	VP, Finance and Accounting	Grant, award, or other acquisition of securities at price $ 0.00 per share.	13 Feb 2025	185,540	185,540	-		-	Stock Option (Right to Buy)
Kristen L. Alexander	VP, Finance and Accounting	Grant, award, or other acquisition of securities at price $ 0.00 per share.	13 Feb 2025	185,540	185,540	-		-	Restricted Stock Units
Craig B. Granowitz	SVP, Chief Medical Officer	Grant, award, or other acquisition of securities at price $ 0.00 per share.	13 Feb 2025	606,780	606,780	-		-	Restricted Stock Units
Craig B. Granowitz	SVP, Chief Medical Officer	Grant, award, or other acquisition of securities at price $ 0.00 per share.	13 Feb 2025	910,170	910,170	-		-	Stock Option (Right to Buy)
Wendy E. McDermott	SVP, Human Resources	Grant, award, or other acquisition of securities at price $ 0.00 per share.	13 Feb 2025	649,780	649,780	-		-	Stock Option (Right to Buy)
Wendy E. McDermott	SVP, Human Resources	Grant, award, or other acquisition of securities at price $ 0.00 per share.	13 Feb 2025	433,180	433,180	-		-	Restricted Stock Units
Michael Exton	Director, Chief Executive Officer	Grant, award, or other acquisition of securities at price $ 0.00 per share.	13 Feb 2025	1,509,790	1,509,790	-		-	Restricted Stock Units
Michael Exton	Director, Chief Executive Officer	Grant, award, or other acquisition of securities at price $ 0.00 per share.	13 Feb 2025	2,264,690	2,264,690	-		-	Stock Option (Right to Buy)
Brian Corrigan	SVP, Regulatory & QA		13 Feb 2025	448,660	448,660	-		-	Restricted Stock Units
Brian Corrigan	SVP, Regulatory & QA		13 Feb 2025	673,000	673,000	-		-	Stock Option (Right to Buy)
Lisa DeFrancesco	VP, IR and Corp Comm	Grant, award, or other acquisition of securities at price $ 0.00 per share.	13 Feb 2025	576,850	576,850	-		-	Stock Option (Right to Buy)
Lisa DeFrancesco	VP, IR and Corp Comm	Grant, award, or other acquisition of securities at price $ 0.00 per share.	13 Feb 2025	384,570	384,570	-		-	Restricted Stock Units
Scott M. Coiante	SVP, Chief Financial Officer	Grant, award, or other acquisition of securities at price $ 0.00 per share.	02 Jan 2025	230,000	230,000	-		-	Stock Option (Right to Buy)
Ivan H. Cheung	Director	Grant, award, or other acquisition of securities at price $ 0.00 per share.	02 Dec 2024	186,685	186,685	-		-	Stock Option (Right to Buy)
Brian Corrigan	SVP, Regulatory & QA		12 Aug 2024	200,000	200,000	-		-	Stock Option (Right to Buy)
Jeffrey L. Wade	President and COO	Grant, award, or other acquisition of securities at price $ 0.00 per share.	08 Jul 2024	307,000	307,000	-		-	Stock Option (Right to Buy)
Michael Exton	Director, Chief Executive Officer	Grant, award, or other acquisition of securities at price $ 0.00 per share.	08 Jul 2024	1,675,000	1,675,000	-		-	Stock Option (Right to Buy)
Raymond Debbane	Director	Grant, award, or other acquisition of securities at price $ 0.00 per share.	13 May 2024	36,810	36,810	-		-	Restricted Stock Units
Samuel L. Barker	Director	Grant, award, or other acquisition of securities at price $ 0.00 per share.	13 May 2024	44,906	44,906	-		-	Stock Option (Right to Buy)
Samuel L. Barker	Director	Grant, award, or other acquisition of securities at price $ 0.00 per share.	13 May 2024	36,810	36,810	-		-	Restricted Stock Units
Christopher J. Sobecki	Director	Grant, award, or other acquisition of securities at price $ 0.00 per share.	13 May 2024	44,906	44,906	-		-	Stock Option (Right to Buy)
Christopher J. Sobecki	Director	Grant, award, or other acquisition of securities at price $ 0.00 per share.	13 May 2024	36,810	36,810	-		-	Restricted Stock Units
Philippe J. Amouyal	Director	Grant, award, or other acquisition of securities at price $ 0.00 per share.	13 May 2024	44,906	44,906	-		-	Stock Option (Right to Buy)
Philippe J. Amouyal	Director	Grant, award, or other acquisition of securities at price $ 0.00 per share.	13 May 2024	36,810	36,810	-		-	Restricted Stock Units
Judith L. Swain	Director	Grant, award, or other acquisition of securities at price $ 0.00 per share.	13 May 2024	44,906	44,906	-		-	Stock Option (Right to Buy)
Judith L. Swain	Director	Grant, award, or other acquisition of securities at price $ 0.00 per share.	13 May 2024	36,810	36,810	-		-	Restricted Stock Units
Robert J. Lefkowitz	Director	Grant, award, or other acquisition of securities at price $ 0.00 per share.	13 May 2024	44,906	44,906	-		-	Stock Option (Right to Buy)
Robert J. Lefkowitz	Director	Grant, award, or other acquisition of securities at price $ 0.00 per share.	13 May 2024	36,810	36,810	-		-	Restricted Stock Units
Diane E. Sullivan	Director	Grant, award, or other acquisition of securities at price $ 0.00 per share.	13 May 2024	36,810	36,810	-		-	Restricted Stock Units
Diane E. Sullivan	Director	Grant, award, or other acquisition of securities at price $ 0.00 per share.	13 May 2024	44,906	44,906	-		-	Stock Option (Right to Buy)
Raymond Debbane	Director	Grant, award, or other acquisition of securities at price $ 0.00 per share.	13 May 2024	44,906	44,906	-		-	Stock Option (Right to Buy)
Raymond Debbane	Director	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	28 Apr 2024	8,032	1,348,879 (1%)	0%		0	Common Stock
Raymond Debbane	Director	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	28 Apr 2024	8,032	0	-		-	Restricted Stock Units
Samuel L. Barker	Director	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	28 Apr 2024	8,032	0	-		-	Restricted Stock Units
Samuel L. Barker	Director	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	28 Apr 2024	8,032	87,649 (0%)	0%		0	Common Stock
Christopher J. Sobecki	Director	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	28 Apr 2024	8,032	167,055 (0%)	0%		0	Common Stock
Christopher J. Sobecki	Director	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	28 Apr 2024	8,032	0	-		-	Restricted Stock Units
Philippe J. Amouyal	Director	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	28 Apr 2024	8,032	0	-		-	Restricted Stock Units
Philippe J. Amouyal	Director	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	28 Apr 2024	8,032	248,364 (0%)	0%		0	Common Stock
Judith L. Swain	Director	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	28 Apr 2024	8,032	48,364 (0%)	0%		0	Common Stock
Judith L. Swain	Director	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	28 Apr 2024	8,032	0	-		-	Restricted Stock Units
Robert J. Lefkowitz	Director	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	28 Apr 2024	8,032	0	-		-	Restricted Stock Units
Robert J. Lefkowitz	Director	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	28 Apr 2024	8,032	48,364 (0%)	0%		0	Common Stock
B. Kassler-Taub Kenneth	SVP, Regulatory & QA		28 Feb 2024	27,556	154,268 (0%)	0%		-	Common Stock
Crum T. Brian	SVP, General Counsel & Secr.	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	28 Feb 2024	8,750	0	-		-	Restricted Stock Units
T. Crum Brian	SVP, General Counsel & Secr.	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	28 Feb 2024	33,457	203,101 (0%)	0%		-	Common Stock
Lonnel Coats	Director, Chief Executive Officer	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	28 Feb 2024	33,333	0	-		-	Restricted Stock Units
T. Brian Crum	SVP, General Counsel & Secr.	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	28 Feb 2024	26,096	26,097	-		-	Restricted Stock Units
B. Kassler-Taub Kenneth	SVP, Regulatory & QA		28 Feb 2024	7,087	126,712 (0%)	0%		-	Common Stock
Jeffrey L. Wade	President and CFO	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	28 Feb 2024	37,274	312,792 (0%)	0%		-	Common Stock
Kassler-Taub Kenneth B.	SVP, Regulatory & QA		28 Feb 2024	32,757	187,025 (0%)	0%		-	Common Stock
Crum T. Brian	SVP, General Counsel & Secr.	Payment of exercise price or tax liability using portion of securities received from the company at price $ 2.62 per share.	28 Feb 2024	25,604	177,497 (0%)	0%	2.6	67,082	Common Stock
Alexander L. Kristen	VP, Finance and Accounting	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	28 Feb 2024	15,927	59,593 (0%)	0%		-	Common Stock
McDermott Wendy E.	VP, Human Resources	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	28 Feb 2024	18,944	18,943	-		-	Restricted Stock Units
Craig Granowitz B.	SVP, Chief Medical Officer	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	28 Feb 2024	27,916	43,101 (0%)	0%		-	Common Stock
Kassler-Taub Kenneth B.	SVP, Regulatory & QA		28 Feb 2024	7,087	0	-		-	Restricted Stock Units
Alan J. Main	EVP, Innov & Chem Sciences		28 Feb 2024	32,903	280,132 (0%)	0%		-	Common Stock
Alexander L. Kristen	VP, Finance and Accounting	Payment of exercise price or tax liability using portion of securities received from the company at price $ 2.62 per share.	28 Feb 2024	11,793	47,800 (0%)	0%	2.6	30,898	Common Stock
McDermott E. Wendy	VP, Human Resources	Payment of exercise price or tax liability using portion of securities received from the company at price $ 2.62 per share.	28 Feb 2024	22,425	52,694 (0%)	0%	2.6	58,754	Common Stock
Coats Lonnel	Director, Chief Executive Officer	Payment of exercise price or tax liability using portion of securities received from the company at price $ 2.62 per share.	28 Feb 2024	61,371	1,098,068 (1%)	0%	2.6	160,792	Common Stock
Wade Jeffrey L.	President and CFO	Payment of exercise price or tax liability using portion of securities received from the company at price $ 2.62 per share.	28 Feb 2024	37,691	324,214 (0%)	0%	2.6	98,750	Common Stock
Granowitz Craig B.	SVP, Chief Medical Officer	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	28 Feb 2024	35,790	78,891 (0%)	0%		-	Common Stock
Jeffrey Wade L.	President and CFO	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	28 Feb 2024	11,177	275,518 (0%)	0%		-	Common Stock
Kassler-Taub Kenneth B.	SVP, Regulatory & QA		28 Feb 2024	32,757	65,513	-		-	Restricted Stock Units
Kristen L. Alexander	VP, Finance and Accounting	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	28 Feb 2024	10,616	10,617	-		-	Restricted Stock Units
Coats Lonnel	Director, Chief Executive Officer	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	28 Feb 2024	120,383	240,767	-		-	Restricted Stock Units
Wade Jeffrey L.	President and CFO	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	28 Feb 2024	37,274	37,273	-		-	Restricted Stock Units
B. Craig Granowitz	SVP, Chief Medical Officer	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	28 Feb 2024	27,916	27,917	-		-	Restricted Stock Units
B. Kenneth Kassler-Taub	SVP, Regulatory & QA		28 Feb 2024	27,556	27,557	-		-	Restricted Stock Units
McDermott Wendy E.	VP, Human Resources	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	28 Feb 2024	27,697	55,393	-		-	Restricted Stock Units
Coats Lonnel	Director, Chief Executive Officer	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	28 Feb 2024	33,333	947,692 (0%)	0%		-	Common Stock
J. Main Alan	EVP, Innov & Chem Sciences		28 Feb 2024	25,666	25,667	-		-	Restricted Stock Units
McDermott Wendy E.	VP, Human Resources	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	28 Feb 2024	27,697	75,119 (0%)	0%		-	Common Stock
Crum T. Brian	SVP, General Counsel & Secr.	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	28 Feb 2024	33,457	66,913	-		-	Restricted Stock Units
Alan Main J.	EVP, Innov & Chem Sciences		28 Feb 2024	8,977	0	-		-	Restricted Stock Units
Alan J. Main	EVP, Innov & Chem Sciences		28 Feb 2024	32,903	65,807	-		-	Restricted Stock Units
Crum Brian T.	SVP, General Counsel & Secr.	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	28 Feb 2024	26,096	169,644 (0%)	0%		-	Common Stock
Lonnel Coats	Director, Chief Executive Officer	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	28 Feb 2024	91,364	91,363	-		-	Restricted Stock Units
Kristen Alexander L.	VP, Finance and Accounting	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	28 Feb 2024	2,700	0	-		-	Restricted Stock Units
J. Alan Main	EVP, Innov & Chem Sciences		28 Feb 2024	25,666	247,229 (0%)	0%		-	Common Stock
Kristen L. Alexander	VP, Finance and Accounting	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	28 Feb 2024	10,616	43,666 (0%)	0%		-	Common Stock
L. Jeffrey Wade	President and CFO	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	28 Feb 2024	11,177	0	-		-	Restricted Stock Units
Kristen Alexander L.	VP, Finance and Accounting	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	28 Feb 2024	2,700	33,050 (0%)	0%		-	Common Stock
Lonnel Coats	Director, Chief Executive Officer	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	28 Feb 2024	91,364	1,039,056 (0%)	0%		-	Common Stock
Alexander Kristen L.	VP, Finance and Accounting	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	28 Feb 2024	15,927	31,853	-		-	Restricted Stock Units
Main J. Alan	EVP, Innov & Chem Sciences		28 Feb 2024	8,977	221,563 (0%)	0%		-	Common Stock
Jeffrey Wade L.	President and CFO	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	28 Feb 2024	49,113	361,905 (0%)	0%		-	Common Stock
Lonnel Coats	Director, Chief Executive Officer	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	28 Feb 2024	120,383	1,159,439 (1%)	0%		-	Common Stock
Alan J. Main	EVP, Innov & Chem Sciences		28 Feb 2024	24,408	255,724 (0%)	0%	2.6	63,949	Common Stock
Granowitz B. Craig	SVP, Chief Medical Officer	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	28 Feb 2024	35,790	71,580	-		-	Restricted Stock Units
B. Kassler-Taub Kenneth	SVP, Regulatory & QA		28 Feb 2024	24,353	162,672 (0%)	0%	2.6	63,805	Common Stock
McDermott Wendy E.	VP, Human Resources	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	28 Feb 2024	18,944	47,422 (0%)	0%		-	Common Stock
Wade Jeffrey L.	President and CFO	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	28 Feb 2024	49,113	98,227	-		-	Restricted Stock Units
B. Granowitz Craig	SVP, Chief Medical Officer	Payment of exercise price or tax liability using portion of securities received from the company at price $ 2.62 per share.	28 Feb 2024	31,265	47,626 (0%)	0%	2.6	81,914	Common Stock
Crum T. Brian	SVP, General Counsel & Secr.	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	28 Feb 2024	8,750	143,548 (0%)	0%		-	Common Stock
E. McDermott Wendy	VP, Human Resources	Grant, award, or other acquisition of securities at price $ 0.00 per share.	08 Feb 2024	156,950	156,950	-		-	Restricted Stock Units
Kristen L. Alexander	VP, Finance and Accounting	Grant, award, or other acquisition of securities at price $ 0.00 per share.	08 Feb 2024	59,660	59,660	-		-	Stock Option (Right to Buy)
Granowitz B. Craig	SVP, Chief Medical Officer	Grant, award, or other acquisition of securities at price $ 0.00 per share.	08 Feb 2024	222,680	222,680	-		-	Restricted Stock Units
Lonnel Coats	Director, Chief Executive Officer	Grant, award, or other acquisition of securities at price $ 0.00 per share.	08 Feb 2024	770,420	770,420	-		-	Restricted Stock Units
B. Kenneth Kassler-Taub	SVP, Regulatory & QA		08 Feb 2024	203,810	203,810	-		-	Stock Option (Right to Buy)
Kenneth B. Kassler-Taub	SVP, Regulatory & QA		08 Feb 2024	203,810	203,810	-		-	Restricted Stock Units
Crum Brian T.	SVP, General Counsel & Secr.	Grant, award, or other acquisition of securities at price $ 0.00 per share.	08 Feb 2024	208,160	208,160	-		-	Stock Option (Right to Buy)
Lonnel Coats	Director, Chief Executive Officer	Grant, award, or other acquisition of securities at price $ 0.00 per share.	08 Feb 2024	770,420	770,420	-		-	Stock Option (Right to Buy)
Craig B. Granowitz	SVP, Chief Medical Officer	Grant, award, or other acquisition of securities at price $ 0.00 per share.	08 Feb 2024	222,680	222,680	-		-	Stock Option (Right to Buy)
E. Wendy McDermott	VP, Human Resources	Grant, award, or other acquisition of securities at price $ 0.00 per share.	08 Feb 2024	156,950	156,950	-		-	Stock Option (Right to Buy)
L. Wade Jeffrey	President and CFO	Grant, award, or other acquisition of securities at price $ 0.00 per share.	08 Feb 2024	314,320	314,320	-		-	Restricted Stock Units
Wade L. Jeffrey	President and CFO	Grant, award, or other acquisition of securities at price $ 0.00 per share.	08 Feb 2024	314,320	314,320	-		-	Stock Option (Right to Buy)
Garner Thomas	SVP, Chief Commercial Officer		08 Feb 2024	227,130	227,130	-		-	Restricted Stock Units
Alexander L. Kristen	VP, Finance and Accounting	Grant, award, or other acquisition of securities at price $ 0.00 per share.	08 Feb 2024	59,660	59,660	-		-	Restricted Stock Units
Main J. Alan	EVP, Innov & Chem Sciences		08 Feb 2024	204,730	204,730	-		-	Stock Option (Right to Buy)
J. Main Alan	EVP, Innov & Chem Sciences		08 Feb 2024	204,730	204,730	-		-	Restricted Stock Units
T. Crum Brian	SVP, General Counsel & Secr.	Grant, award, or other acquisition of securities at price $ 0.00 per share.	08 Feb 2024	208,160	208,160	-		-	Restricted Stock Units
Garner Thomas	SVP, Chief Commercial Officer		08 Feb 2024	227,130	227,130	-		-	Stock Option (Right to Buy)
Wendy E. McDermott	VP, Human Resources	Purchase of securities on an exchange or from another person at price $ 1.84 per share.	04 Aug 2023	6,000	28,478 (0%)	0%	1.8	11,040	Common Stock
Diane Sullivan	Director	Grant, award, or other acquisition of securities at price $ 0.00 per share.	27 Jul 2023	96,515	96,515	-		-	Stock Option (Right to Buy)
Lonnel Coats	Director, Chief Executive Officer	Purchase of securities on an exchange or from another person at price $ 2.16 per share.	29 Jun 2023	10,000	814,359 (0%)	0%	2.2	21,600	Common Stock
Lonnel Coats	Director, Chief Executive Officer	Purchase of securities on an exchange or from another person at price $ 2.50 per share.	23 Jun 2023	10,000	794,359 (0%)	0%	2.5	24,950	Common Stock
Lonnel Coats	Director, Chief Executive Officer	Purchase of securities on an exchange or from another person at price $ 2.18 per share.	23 Jun 2023	10,000	804,359 (0%)	0%	2.2	21,792	Common Stock
Wendy E. McDermott	VP, Human Resources	Purchase of securities on an exchange or from another person at price $ 2.43 per share.	23 Jun 2023	10,000	22,478 (0%)	0%	2.4	24,300	Common Stock
Lonnel Coats	Director, Chief Executive Officer	Purchase of securities on an exchange or from another person at price $ 2.31 per share.	22 Jun 2023	40,000	784,359 (0%)	0%	2.3	92,400	Common Stock
Jeffrey L. Wade	President and CFO	Purchase of securities on an exchange or from another person at price $ 2.32 per share.	20 Jun 2023	2,000	254,341 (0%)	0%	2.3	4,650	Common Stock
Jeffrey L. Wade	President and CFO	Purchase of securities on an exchange or from another person at price $ 2.34 per share.	20 Jun 2023	10,000	252,341 (0%)	0%	2.3	23,350	Common Stock
Frank P. Palantoni	Director	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	21 May 2023	9,302	40,332 (0%)	0%		0	Common Stock
Frank P. Palantoni	Director	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	21 May 2023	9,302	0	-		-	Restricted Stock Units
Raymond Debbane	Director	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	21 May 2023	9,302	0	-		-	Restricted Stock Units
Raymond Debbane	Director	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	21 May 2023	9,302	340,847 (0%)	0%		0	Common Stock
Samuel L. Barker	Director	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	21 May 2023	9,302	79,617 (0%)	0%		0	Common Stock
Samuel L. Barker	Director	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	21 May 2023	9,302	0	-		-	Restricted Stock Units
Alan S. Nies	Director	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	21 May 2023	9,302	41,046 (0%)	0%		0	Common Stock
Alan S. Nies	Director	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	21 May 2023	9,302	0	-		-	Restricted Stock Units
Christopher J. Sobecki	Director	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	21 May 2023	9,302	159,023 (0%)	0%		0	Common Stock
Christopher J. Sobecki	Director	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	21 May 2023	9,302	0	-		-	Restricted Stock Units
Philippe J. Amouyal	Director	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	21 May 2023	9,302	0	-		-	Restricted Stock Units
Philippe J. Amouyal	Director	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	21 May 2023	9,302	40,332 (0%)	0%		0	Common Stock
Judith L. Swain	Director	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	21 May 2023	9,302	0	-		-	Restricted Stock Units
Judith L. Swain	Director	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	21 May 2023	9,302	40,332 (0%)	0%		0	Common Stock
Robert J. Lefkowitz	Director	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	21 May 2023	9,302	0	-		-	Restricted Stock Units
Robert J. Lefkowitz	Director	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	21 May 2023	9,302	40,332 (0%)	0%		0	Common Stock
Frank P. Palantoni	Director	Grant, award, or other acquisition of securities at price $ 0.00 per share.	28 Apr 2023	12,658	12,658	-		-	Stock Option (Right to Buy)
Frank P. Palantoni	Director	Grant, award, or other acquisition of securities at price $ 0.00 per share.	28 Apr 2023	8,032	8,032	-		-	Restricted Stock Units
Alan S. Nies	Director	Grant, award, or other acquisition of securities at price $ 0.00 per share.	28 Apr 2023	8,032	8,032	-		-	Restricted Stock Units
Alan S. Nies	Director	Grant, award, or other acquisition of securities at price $ 0.00 per share.	28 Apr 2023	12,658	12,658	-		-	Stock Option (Right to Buy)
Christopher J. Sobecki	Director	Grant, award, or other acquisition of securities at price $ 0.00 per share.	28 Apr 2023	8,032	8,032	-		-	Restricted Stock Units
Christopher J. Sobecki	Director	Grant, award, or other acquisition of securities at price $ 0.00 per share.	28 Apr 2023	12,658	12,658	-		-	Stock Option (Right to Buy)
Philippe J. Amouyal	Director	Grant, award, or other acquisition of securities at price $ 0.00 per share.	28 Apr 2023	12,658	12,658	-		-	Stock Option (Right to Buy)
Philippe J. Amouyal	Director	Grant, award, or other acquisition of securities at price $ 0.00 per share.	28 Apr 2023	8,032	8,032	-		-	Restricted Stock Units
Judith L. Swain	Director	Grant, award, or other acquisition of securities at price $ 0.00 per share.	28 Apr 2023	8,032	8,032	-		-	Restricted Stock Units
Judith L. Swain	Director	Grant, award, or other acquisition of securities at price $ 0.00 per share.	28 Apr 2023	12,658	12,658	-		-	Stock Option (Right to Buy)
Robert J. Lefkowitz	Director	Grant, award, or other acquisition of securities at price $ 0.00 per share.	28 Apr 2023	8,032	8,032	-		-	Restricted Stock Units
Robert J. Lefkowitz	Director	Grant, award, or other acquisition of securities at price $ 0.00 per share.	28 Apr 2023	12,658	12,658	-		-	Stock Option (Right to Buy)
Alan J. Main	EVP, Innov & Chem Sciences		28 Feb 2023	23,300	0	-		-	Restricted Stock Units
Alan J. Main	EVP, Innov & Chem Sciences		28 Feb 2023	20,946	212,586 (0%)	0%	2.2	45,453	Common Stock
Alan J. Main	EVP, Innov & Chem Sciences		28 Feb 2023	8,976	8,977	-		-	Restricted Stock Units
Alan J. Main	EVP, Innov & Chem Sciences		28 Feb 2023	25,667	233,532 (0%)	0%		-	Common Stock
Alan J. Main	EVP, Innov & Chem Sciences		28 Feb 2023	8,976	207,865 (0%)	0%		-	Common Stock
Alan J. Main	EVP, Innov & Chem Sciences		28 Feb 2023	25,667	51,333	-		-	Restricted Stock Units
Alan J. Main	EVP, Innov & Chem Sciences		28 Feb 2023	23,300	198,889 (0%)	0%		-	Common Stock
Jeffrey L. Wade	President and CFO	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	28 Feb 2023	37,273	74,547	-		-	Restricted Stock Units
Jeffrey L. Wade	President and CFO	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	28 Feb 2023	11,176	11,177	-		-	Restricted Stock Units
Jeffrey L. Wade	President and CFO	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	28 Feb 2023	30,467	0	-		-	Restricted Stock Units
Jeffrey L. Wade	President and CFO	Payment of exercise price or tax liability using portion of securities received from the company at price $ 2.17 per share.	28 Feb 2023	30,255	242,341 (0%)	0%	2.2	65,653	Common Stock
Jeffrey L. Wade	President and CFO	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	28 Feb 2023	37,273	272,596 (0%)	0%		-	Common Stock
Jeffrey L. Wade	President and CFO	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	28 Feb 2023	11,176	235,323 (0%)	0%		-	Common Stock
Jeffrey L. Wade	President and CFO	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	28 Feb 2023	30,467	224,147 (0%)	0%		-	Common Stock
Brian T. Crum	SVP, General Counsel & Secr.	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	28 Feb 2023	26,097	52,193	-		-	Restricted Stock Units
Brian T. Crum	SVP, General Counsel & Secr.	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	28 Feb 2023	8,750	8,750	-		-	Restricted Stock Units
Brian T. Crum	SVP, General Counsel & Secr.	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	28 Feb 2023	21,030	0	-		-	Restricted Stock Units
Brian T. Crum	SVP, General Counsel & Secr.	Payment of exercise price or tax liability using portion of securities received from the company at price $ 2.17 per share.	28 Feb 2023	20,537	134,798 (0%)	0%	2.2	44,565	Common Stock
Brian T. Crum	SVP, General Counsel & Secr.	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	28 Feb 2023	26,097	155,335 (0%)	0%		-	Common Stock
Brian T. Crum	SVP, General Counsel & Secr.	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	28 Feb 2023	8,750	129,238 (0%)	0%		-	Common Stock
Brian T. Crum	SVP, General Counsel & Secr.	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	28 Feb 2023	21,030	120,488 (0%)	0%		-	Common Stock
Lonnel Coats	Director, Chief Executive Officer	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	28 Feb 2023	84,630	0	-		-	Restricted Stock Units
Lonnel Coats	Director, Chief Executive Officer	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	28 Feb 2023	84,630	670,633 (0%)	0%		-	Common Stock
Lonnel Coats	Director, Chief Executive Officer	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	28 Feb 2023	33,334	703,967 (0%)	0%		-	Common Stock
Lonnel Coats	Director, Chief Executive Officer	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	28 Feb 2023	91,363	795,330 (0%)	0%		-	Common Stock
Lonnel Coats	Director, Chief Executive Officer	Payment of exercise price or tax liability using portion of securities received from the company at price $ 2.17 per share.	28 Feb 2023	50,971	744,359 (0%)	0%	2.2	110,607	Common Stock
Lonnel Coats	Director, Chief Executive Officer	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	28 Feb 2023	33,334	33,333	-		-	Restricted Stock Units
Lonnel Coats	Director, Chief Executive Officer	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	28 Feb 2023	91,363	182,727	-		-	Restricted Stock Units
Kristen L. Alexander	VP, Finance and Accounting	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	28 Feb 2023	10,617	21,233	-		-	Restricted Stock Units
Kristen L. Alexander	VP, Finance and Accounting	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	28 Feb 2023	2,700	2,700	-		-	Restricted Stock Units
Kristen L. Alexander	VP, Finance and Accounting	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	28 Feb 2023	5,400	0	-		-	Restricted Stock Units
Kristen L. Alexander	VP, Finance and Accounting	Payment of exercise price or tax liability using portion of securities received from the company at price $ 2.17 per share.	28 Feb 2023	5,330	30,350 (0%)	0%	2.2	11,566	Common Stock
Kristen L. Alexander	VP, Finance and Accounting	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	28 Feb 2023	10,617	35,680 (0%)	0%		-	Common Stock
Kristen L. Alexander	VP, Finance and Accounting	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	28 Feb 2023	2,700	25,063 (0%)	0%		-	Common Stock
Kristen L. Alexander	VP, Finance and Accounting	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	28 Feb 2023	5,400	22,363 (0%)	0%		-	Common Stock
Craig B. Granowitz	SVP, Chief Medical Officer	Payment of exercise price or tax liability using portion of securities received from the company at price $ 2.17 per share.	28 Feb 2023	12,732	15,185 (0%)	0%	2.2	27,628	Common Stock
Craig B. Granowitz	SVP, Chief Medical Officer	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	28 Feb 2023	27,917	27,917 (0%)	0%		-	Common Stock
Craig B. Granowitz	SVP, Chief Medical Officer	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	28 Feb 2023	27,917	55,833	-		-	Restricted Stock Units
Kenneth B. Kassler-Taub	SVP, Regulatory & QA		28 Feb 2023	18,243	104,100 (0%)	0%		-	Common Stock
Kenneth B. Kassler-Taub	SVP, Regulatory & QA		28 Feb 2023	27,557	55,113	-		-	Restricted Stock Units
Kenneth B. Kassler-Taub	SVP, Regulatory & QA		28 Feb 2023	7,086	7,087	-		-	Restricted Stock Units
Kenneth B. Kassler-Taub	SVP, Regulatory & QA		28 Feb 2023	18,243	0	-		-	Restricted Stock Units
Kenneth B. Kassler-Taub	SVP, Regulatory & QA		28 Feb 2023	19,118	119,625 (0%)	0%	2.2	41,486	Common Stock
Kenneth B. Kassler-Taub	SVP, Regulatory & QA		28 Feb 2023	27,557	138,743 (0%)	0%		-	Common Stock
Kenneth B. Kassler-Taub	SVP, Regulatory & QA		28 Feb 2023	7,086	111,186 (0%)	0%		-	Common Stock
Kiernan A. Seth	VP, Chief Commercial Officer	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	28 Feb 2023	22,963	45,927	-		-	Restricted Stock Units
Kiernan A. Seth	VP, Chief Commercial Officer	Payment of exercise price or tax liability using portion of securities received from the company at price $ 2.17 per share.	28 Feb 2023	11,813	53,136 (0%)	0%	2.2	25,634	Common Stock
Kiernan A. Seth	VP, Chief Commercial Officer	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	28 Feb 2023	14,833	0	-		-	Restricted Stock Units
Kiernan A. Seth	VP, Chief Commercial Officer	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	28 Feb 2023	5,286	5,287	-		-	Restricted Stock Units
Kiernan A. Seth	VP, Chief Commercial Officer	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	28 Feb 2023	14,833	36,700 (0%)	0%		-	Common Stock
Kiernan A. Seth	VP, Chief Commercial Officer	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	28 Feb 2023	5,286	41,986 (0%)	0%		-	Common Stock
Kiernan A. Seth	VP, Chief Commercial Officer	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	28 Feb 2023	22,963	64,949 (0%)	0%		-	Common Stock
Wendy E. McDermott	VP, Human Resources	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	28 Feb 2023	18,943	18,943 (0%)	0%		-	Common Stock
Wendy E. McDermott	VP, Human Resources	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	28 Feb 2023	18,943	37,887	-		-	Restricted Stock Units
Wendy E. McDermott	VP, Human Resources	Payment of exercise price or tax liability using portion of securities received from the company at price $ 2.17 per share.	28 Feb 2023	6,465	12,478 (0%)	0%	2.2	14,029	Common Stock
Alan J. Main	EVP, Innov & Chem Sciences		09 Feb 2023	296,130	296,130	-		-	Stock Option (Right to Buy)
Alan J. Main	EVP, Innov & Chem Sciences		09 Feb 2023	98,710	98,710	-		-	Restricted Stock Units
Jeffrey L. Wade	President and CFO	Grant, award, or other acquisition of securities at price $ 0.00 per share.	09 Feb 2023	147,340	147,340	-		-	Restricted Stock Units
Jeffrey L. Wade	President and CFO	Grant, award, or other acquisition of securities at price $ 0.00 per share.	09 Feb 2023	442,030	442,030	-		-	Stock Option (Right to Buy)
Brian T. Crum	SVP, General Counsel & Secr.	Grant, award, or other acquisition of securities at price $ 0.00 per share.	09 Feb 2023	100,370	100,370	-		-	Restricted Stock Units
Brian T. Crum	SVP, General Counsel & Secr.	Grant, award, or other acquisition of securities at price $ 0.00 per share.	09 Feb 2023	301,100	301,100	-		-	Stock Option (Right to Buy)
Lonnel Coats	Director, Chief Executive Officer	Grant, award, or other acquisition of securities at price $ 0.00 per share.	09 Feb 2023	1,083,440	1,083,440	-		-	Stock Option (Right to Buy)
Lonnel Coats	Director, Chief Executive Officer	Grant, award, or other acquisition of securities at price $ 0.00 per share.	09 Feb 2023	361,150	361,150	-		-	Restricted Stock Units
Kristen L. Alexander	VP, Finance and Accounting	Grant, award, or other acquisition of securities at price $ 0.00 per share.	09 Feb 2023	71,670	71,670	-		-	Stock Option (Right to Buy)
Kristen L. Alexander	VP, Finance and Accounting	Grant, award, or other acquisition of securities at price $ 0.00 per share.	09 Feb 2023	47,780	47,780	-		-	Restricted Stock Units
Craig B. Granowitz	SVP, Chief Medical Officer	Grant, award, or other acquisition of securities at price $ 0.00 per share.	09 Feb 2023	322,110	322,110	-		-	Stock Option (Right to Buy)
Craig B. Granowitz	SVP, Chief Medical Officer	Grant, award, or other acquisition of securities at price $ 0.00 per share.	09 Feb 2023	107,370	107,370	-		-	Restricted Stock Units
Kenneth B. Kassler-Taub	SVP, Regulatory & QA		09 Feb 2023	98,270	98,270	-		-	Restricted Stock Units
Kenneth B. Kassler-Taub	SVP, Regulatory & QA		09 Feb 2023	294,810	294,810	-		-	Stock Option (Right to Buy)
Kiernan A. Seth	VP, Chief Commercial Officer	Grant, award, or other acquisition of securities at price $ 0.00 per share.	09 Feb 2023	280,100	280,100	-		-	Stock Option (Right to Buy)
Kiernan A. Seth	VP, Chief Commercial Officer	Grant, award, or other acquisition of securities at price $ 0.00 per share.	09 Feb 2023	93,370	93,370	-		-	Restricted Stock Units
Wendy E. McDermott	VP, Human Resources	Grant, award, or other acquisition of securities at price $ 0.00 per share.	09 Feb 2023	83,090	83,090	-		-	Restricted Stock Units
Wendy E. McDermott	VP, Human Resources	Grant, award, or other acquisition of securities at price $ 0.00 per share.	09 Feb 2023	249,280	249,280	-		-	Stock Option (Right to Buy)
Raymond Debbane	Director	Purchase of securities on an exchange or from another person at price $ 2.50 per share.	01 Aug 2022	982,600	5,303,814 (4%)	0%	2.5	2,456,500	Common Stock
Frank P. Palantoni	Director	Grant, award, or other acquisition of securities at price $ 0.00 per share.	21 May 2022	14,402	14,402	-		-	Stock Option (Right to Buy)
Frank P. Palantoni	Director	Grant, award, or other acquisition of securities at price $ 0.00 per share.	21 May 2022	9,302	9,302	-		-	Restricted Stock Units
Raymond Debbane	Director	Grant, award, or other acquisition of securities at price $ 0.00 per share.	21 May 2022	9,302	9,302	-		-	Restricted Stock Units
Raymond Debbane	Director	Grant, award, or other acquisition of securities at price $ 0.00 per share.	21 May 2022	14,402	14,402	-		-	Stock Option (Right to Buy)
Samuel L. Barker	Director	Grant, award, or other acquisition of securities at price $ 0.00 per share.	21 May 2022	14,402	14,402	-		-	Stock Option (Right to Buy)
Samuel L. Barker	Director	Grant, award, or other acquisition of securities at price $ 0.00 per share.	21 May 2022	9,302	9,302	-		-	Restricted Stock Units
Alan S. Nies	Director	Grant, award, or other acquisition of securities at price $ 0.00 per share.	21 May 2022	9,302	9,302	-		-	Restricted Stock Units
Alan S. Nies	Director	Grant, award, or other acquisition of securities at price $ 0.00 per share.	21 May 2022	14,402	14,402	-		-	Stock Option (Right to Buy)
Christopher J. Sobecki	Director	Grant, award, or other acquisition of securities at price $ 0.00 per share.	21 May 2022	14,402	14,402	-		-	Stock Option (Right to Buy)
Christopher J. Sobecki	Director	Grant, award, or other acquisition of securities at price $ 0.00 per share.	21 May 2022	9,302	9,302	-		-	Restricted Stock Units
Philippe J. Amouyal	Director	Grant, award, or other acquisition of securities at price $ 0.00 per share.	21 May 2022	9,302	9,302	-		-	Restricted Stock Units
Philippe J. Amouyal	Director	Grant, award, or other acquisition of securities at price $ 0.00 per share.	21 May 2022	14,402	14,402	-		-	Stock Option (Right to Buy)
Judith L. Swain	Director	Grant, award, or other acquisition of securities at price $ 0.00 per share.	21 May 2022	14,402	14,402	-		-	Stock Option (Right to Buy)
Judith L. Swain	Director	Grant, award, or other acquisition of securities at price $ 0.00 per share.	21 May 2022	9,302	9,302	-		-	Restricted Stock Units
Robert J. Lefkowitz	Director	Grant, award, or other acquisition of securities at price $ 0.00 per share.	21 May 2022	9,302	9,302	-		-	Restricted Stock Units
Robert J. Lefkowitz	Director	Grant, award, or other acquisition of securities at price $ 0.00 per share.	21 May 2022	14,402	14,402	-		-	Stock Option (Right to Buy)
Frank P. Palantoni	Director	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	30 Apr 2022	4,024	0	-		-	Restricted Stock Units
Frank P. Palantoni	Director	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	30 Apr 2022	4,024	31,030 (0%)	0%		0	Common Stock
Raymond Debbane	Director	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	30 Apr 2022	4,024	331,545 (0%)	0%		0	Common Stock
Raymond Debbane	Director	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	30 Apr 2022	4,024	0	-		-	Restricted Stock Units
Samuel L. Barker	Director	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	30 Apr 2022	4,024	70,315 (0%)	0%		0	Common Stock
Samuel L. Barker	Director	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	30 Apr 2022	4,024	0	-		-	Restricted Stock Units
Alan S. Nies	Director	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	30 Apr 2022	4,024	31,744 (0%)	0%		0	Common Stock
Alan S. Nies	Director	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	30 Apr 2022	4,024	0	-		-	Restricted Stock Units
Christopher J. Sobecki	Director	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	30 Apr 2022	4,024	149,721 (0%)	0%		0	Common Stock
Christopher J. Sobecki	Director	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	30 Apr 2022	4,024	0	-		-	Restricted Stock Units
Philippe J. Amouyal	Director	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	30 Apr 2022	4,024	0	-		-	Restricted Stock Units
Philippe J. Amouyal	Director	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	30 Apr 2022	4,024	31,030 (0%)	0%		0	Common Stock
Judith L. Swain	Director	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	30 Apr 2022	4,024	31,030 (0%)	0%		0	Common Stock
Judith L. Swain	Director	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	30 Apr 2022	4,024	0	-		-	Restricted Stock Units
Robert J. Lefkowitz	Director	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	30 Apr 2022	4,024	31,030 (0%)	0%		0	Common Stock
Robert J. Lefkowitz	Director	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	30 Apr 2022	4,024	0	-		-	Restricted Stock Units
Alan J. Main	EVP, Innov & Chem Sciences		28 Feb 2022	22,373	163,068 (0%)	0%		-	Common Stock
Alan J. Main	EVP, Innov & Chem Sciences		28 Feb 2022	8,977	17,953	-		-	Restricted Stock Units
Alan J. Main	EVP, Innov & Chem Sciences		28 Feb 2022	22,373	0	-		-	Restricted Stock Units
Alan J. Main	EVP, Innov & Chem Sciences		28 Feb 2022	23,300	23,300	-		-	Restricted Stock Units
Alan J. Main	EVP, Innov & Chem Sciences		28 Feb 2022	19,756	175,589 (0%)	0%	2.9	56,305	Common Stock
Alan J. Main	EVP, Innov & Chem Sciences		28 Feb 2022	8,977	195,345 (0%)	0%		-	Common Stock
Alan J. Main	EVP, Innov & Chem Sciences		28 Feb 2022	23,300	186,368 (0%)	0%		-	Common Stock
Jeffrey L. Wade	President and CFO	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	28 Feb 2022	30,466	30,467	-		-	Restricted Stock Units
Jeffrey L. Wade	President and CFO	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	28 Feb 2022	11,177	22,353	-		-	Restricted Stock Units
Jeffrey L. Wade	President and CFO	Payment of exercise price or tax liability using portion of securities received from the company at price $ 2.85 per share.	28 Feb 2022	25,773	193,680 (0%)	0%	2.8	73,453	Common Stock
Jeffrey L. Wade	President and CFO	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	28 Feb 2022	11,177	219,453 (0%)	0%		-	Common Stock
Jeffrey L. Wade	President and CFO	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	28 Feb 2022	30,466	208,276 (0%)	0%		-	Common Stock
Jeffrey L. Wade	President and CFO	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	28 Feb 2022	25,290	177,810 (0%)	0%		-	Common Stock
Jeffrey L. Wade	President and CFO	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	28 Feb 2022	25,290	0	-		-	Restricted Stock Units
Brian T. Crum	SVP, General Counsel & Secr.	Payment of exercise price or tax liability using portion of securities received from the company at price $ 2.85 per share.	28 Feb 2022	15,059	99,458 (0%)	0%	2.8	42,918	Common Stock
Brian T. Crum	SVP, General Counsel & Secr.	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	28 Feb 2022	8,750	114,517 (0%)	0%		-	Common Stock
Brian T. Crum	SVP, General Counsel & Secr.	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	28 Feb 2022	21,030	105,767 (0%)	0%		-	Common Stock
Brian T. Crum	SVP, General Counsel & Secr.	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	28 Feb 2022	11,100	84,737 (0%)	0%		-	Common Stock
Brian T. Crum	SVP, General Counsel & Secr.	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	28 Feb 2022	21,030	21,030	-		-	Restricted Stock Units
Brian T. Crum	SVP, General Counsel & Secr.	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	28 Feb 2022	8,750	17,500	-		-	Restricted Stock Units
Brian T. Crum	SVP, General Counsel & Secr.	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	28 Feb 2022	11,100	0	-		-	Restricted Stock Units
Lonnel Coats	Director, Chief Executive Officer	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	28 Feb 2022	79,380	0	-		-	Restricted Stock Units
Lonnel Coats	Director, Chief Executive Officer	Payment of exercise price or tax liability using portion of securities received from the company at price $ 2.85 per share.	28 Feb 2022	48,053	586,003 (0%)	0%	2.8	136,951	Common Stock
Lonnel Coats	Director, Chief Executive Officer	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	28 Feb 2022	33,333	634,056 (0%)	0%		-	Common Stock
Lonnel Coats	Director, Chief Executive Officer	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	28 Feb 2022	84,630	600,723 (0%)	0%		-	Common Stock
Lonnel Coats	Director, Chief Executive Officer	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	28 Feb 2022	79,380	516,093 (0%)	0%		-	Common Stock
Lonnel Coats	Director, Chief Executive Officer	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	28 Feb 2022	33,333	66,667	-		-	Restricted Stock Units
Lonnel Coats	Director, Chief Executive Officer	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	28 Feb 2022	84,630	84,630	-		-	Restricted Stock Units
Kristen L. Alexander	VP, Finance and Accounting	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	28 Feb 2022	2,700	20,300 (0%)	0%		-	Common Stock
Kristen L. Alexander	VP, Finance and Accounting	Payment of exercise price or tax liability using portion of securities received from the company at price $ 2.85 per share.	28 Feb 2022	3,337	16,963 (0%)	0%	2.8	9,510	Common Stock
Kristen L. Alexander	VP, Finance and Accounting	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	28 Feb 2022	3,200	0	-		-	Restricted Stock Units
Kristen L. Alexander	VP, Finance and Accounting	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	28 Feb 2022	5,400	5,400	-		-	Restricted Stock Units
Kristen L. Alexander	VP, Finance and Accounting	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	28 Feb 2022	2,700	5,400	-		-	Restricted Stock Units
Kristen L. Alexander	VP, Finance and Accounting	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	28 Feb 2022	3,200	12,200 (0%)	0%		-	Common Stock
Kristen L. Alexander	VP, Finance and Accounting	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	28 Feb 2022	5,400	17,600 (0%)	0%		-	Common Stock
Kenneth B. Kassler-Taub	SVP, Regulatory & QA		28 Feb 2022	11,297	0	-		-	Restricted Stock Units
Kenneth B. Kassler-Taub	SVP, Regulatory & QA		28 Feb 2022	11,297	73,767 (0%)	0%		-	Common Stock
Kenneth B. Kassler-Taub	SVP, Regulatory & QA		28 Feb 2022	18,244	92,011 (0%)	0%		-	Common Stock
Kenneth B. Kassler-Taub	SVP, Regulatory & QA		28 Feb 2022	7,087	99,098 (0%)	0%		-	Common Stock
Kenneth B. Kassler-Taub	SVP, Regulatory & QA		28 Feb 2022	13,241	85,857 (0%)	0%	2.9	37,737	Common Stock
Kenneth B. Kassler-Taub	SVP, Regulatory & QA		28 Feb 2022	18,244	18,243	-		-	Restricted Stock Units
Kenneth B. Kassler-Taub	SVP, Regulatory & QA		28 Feb 2022	7,087	14,173	-		-	Restricted Stock Units
Kiernan A. Seth	VP, Chief Commercial Officer	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	28 Feb 2022	5,287	10,573	-		-	Restricted Stock Units
Kiernan A. Seth	VP, Chief Commercial Officer	Payment of exercise price or tax liability using portion of securities received from the company at price $ 2.85 per share.	28 Feb 2022	8,261	21,867 (0%)	0%	2.9	23,544	Common Stock
Kiernan A. Seth	VP, Chief Commercial Officer	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	28 Feb 2022	5,287	30,128 (0%)	0%		-	Common Stock
Kiernan A. Seth	VP, Chief Commercial Officer	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	28 Feb 2022	14,834	24,841 (0%)	0%		-	Common Stock
Kiernan A. Seth	VP, Chief Commercial Officer	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	28 Feb 2022	10,007	10,007 (0%)	0%		-	Common Stock
Kiernan A. Seth	VP, Chief Commercial Officer	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	28 Feb 2022	14,834	14,833	-		-	Restricted Stock Units
Kiernan A. Seth	VP, Chief Commercial Officer	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	28 Feb 2022	10,007	0	-		-	Restricted Stock Units
Alan J. Main	EVP, Innov & Chem Sciences		10 Feb 2022	230,990	230,990	-		-	Stock Option (Right to Buy)
Alan J. Main	EVP, Innov & Chem Sciences		10 Feb 2022	77,000	77,000	-		-	Restricted Stock Units
Jeffrey L. Wade	President and CFO	Grant, award, or other acquisition of securities at price $ 0.00 per share.	10 Feb 2022	111,820	111,820	-		-	Restricted Stock Units
Jeffrey L. Wade	President and CFO	Grant, award, or other acquisition of securities at price $ 0.00 per share.	10 Feb 2022	335,470	335,470	-		-	Stock Option (Right to Buy)
Brian T. Crum	SVP, General Counsel & Secr.	Grant, award, or other acquisition of securities at price $ 0.00 per share.	10 Feb 2022	234,870	234,870	-		-	Stock Option (Right to Buy)
Brian T. Crum	SVP, General Counsel & Secr.	Grant, award, or other acquisition of securities at price $ 0.00 per share.	10 Feb 2022	78,290	78,290	-		-	Restricted Stock Units
Lonnel Coats	Director, Chief Executive Officer	Grant, award, or other acquisition of securities at price $ 0.00 per share.	10 Feb 2022	822,280	822,280	-		-	Stock Option (Right to Buy)
Lonnel Coats	Director, Chief Executive Officer	Grant, award, or other acquisition of securities at price $ 0.00 per share.	10 Feb 2022	274,090	274,090	-		-	Restricted Stock Units
Kristen L. Alexander	VP, Finance and Accounting	Grant, award, or other acquisition of securities at price $ 0.00 per share.	10 Feb 2022	47,780	47,780	-		-	Stock Option (Right to Buy)
Kristen L. Alexander	VP, Finance and Accounting	Grant, award, or other acquisition of securities at price $ 0.00 per share.	10 Feb 2022	31,850	31,850	-		-	Restricted Stock Units
Craig B. Granowitz	SVP, Chief Medical Officer	Grant, award, or other acquisition of securities at price $ 0.00 per share.	10 Feb 2022	83,750	83,750	-		-	Restricted Stock Units
Craig B. Granowitz	SVP, Chief Medical Officer	Grant, award, or other acquisition of securities at price $ 0.00 per share.	10 Feb 2022	251,250	251,250	-		-	Stock Option (Right to Buy)
Kenneth B. Kassler-Taub	SVP, Regulatory & QA		10 Feb 2022	82,670	82,670	-		-	Restricted Stock Units
Kenneth B. Kassler-Taub	SVP, Regulatory & QA		10 Feb 2022	248,010	248,010	-		-	Stock Option (Right to Buy)
Kiernan A. Seth	VP, Chief Commercial Officer	Grant, award, or other acquisition of securities at price $ 0.00 per share.	10 Feb 2022	206,670	206,670	-		-	Stock Option (Right to Buy)
Kiernan A. Seth	VP, Chief Commercial Officer	Grant, award, or other acquisition of securities at price $ 0.00 per share.	10 Feb 2022	68,890	68,890	-		-	Restricted Stock Units
Wendy E. McDermott	VP, Human Resources	Grant, award, or other acquisition of securities at price $ 0.00 per share.	10 Feb 2022	170,500	170,500	-		-	Stock Option (Right to Buy)
Wendy E. McDermott	VP, Human Resources	Grant, award, or other acquisition of securities at price $ 0.00 per share.	10 Feb 2022	56,830	56,830	-		-	Restricted Stock Units
Wendy E. McDermott	VP, Human Resources	Grant, award, or other acquisition of securities at price $ 0.00 per share.	03 Jan 2022	85,185	85,185	-		-	Stock Option (Right to Buy)
Craig B. Granowitz	SVP, Chief Medical Officer	Grant, award, or other acquisition of securities at price $ 0.00 per share.	02 Aug 2021	250,000	250,000	-		-	Stock Option (Right to Buy)
Frank P. Palantoni	Director	Grant, award, or other acquisition of securities at price $ 0.00 per share.	30 Apr 2021	4,024	4,024	-		-	Restricted Stock Units
Frank P. Palantoni	Director	Grant, award, or other acquisition of securities at price $ 0.00 per share.	30 Apr 2021	6,475	6,475	-		-	Stock Option (Right to Buy)
Raymond Debbane	Director	Grant, award, or other acquisition of securities at price $ 0.00 per share.	30 Apr 2021	6,475	6,475	-		-	Stock Option (Right to Buy)
Raymond Debbane	Director	Grant, award, or other acquisition of securities at price $ 0.00 per share.	30 Apr 2021	4,024	4,024	-		-	Restricted Stock Units
Samuel L. Barker	Director	Grant, award, or other acquisition of securities at price $ 0.00 per share.	30 Apr 2021	4,024	4,024	-		-	Restricted Stock Units
Samuel L. Barker	Director	Grant, award, or other acquisition of securities at price $ 0.00 per share.	30 Apr 2021	6,475	6,475	-		-	Stock Option (Right to Buy)
Alan S. Nies	Director	Grant, award, or other acquisition of securities at price $ 0.00 per share.	30 Apr 2021	4,024	4,024	-		-	Restricted Stock Units
Alan S. Nies	Director	Grant, award, or other acquisition of securities at price $ 0.00 per share.	30 Apr 2021	6,475	6,475	-		-	Stock Option (Right to Buy)
Christopher J. Sobecki	Director	Grant, award, or other acquisition of securities at price $ 0.00 per share.	30 Apr 2021	4,024	4,024	-		-	Restricted Stock Units
Christopher J. Sobecki	Director	Grant, award, or other acquisition of securities at price $ 0.00 per share.	30 Apr 2021	6,475	6,475	-		-	Stock Option (Right to Buy)
Philippe J. Amouyal	Director	Grant, award, or other acquisition of securities at price $ 0.00 per share.	30 Apr 2021	6,475	6,475	-		-	Stock Option (Right to Buy)
Philippe J. Amouyal	Director	Grant, award, or other acquisition of securities at price $ 0.00 per share.	30 Apr 2021	4,024	4,024	-		-	Restricted Stock Units
Judith L. Swain	Director	Grant, award, or other acquisition of securities at price $ 0.00 per share.	30 Apr 2021	4,024	4,024	-		-	Restricted Stock Units
Judith L. Swain	Director	Grant, award, or other acquisition of securities at price $ 0.00 per share.	30 Apr 2021	6,475	6,475	-		-	Stock Option (Right to Buy)
Robert J. Lefkowitz	Director	Grant, award, or other acquisition of securities at price $ 0.00 per share.	30 Apr 2021	4,024	4,024	-		-	Restricted Stock Units
Robert J. Lefkowitz	Director	Grant, award, or other acquisition of securities at price $ 0.00 per share.	30 Apr 2021	6,475	6,475	-		-	Stock Option (Right to Buy)
Frank P. Palantoni	Director	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	24 Apr 2021	10,638	0	-		-	Restricted Stock Units
Frank P. Palantoni	Director	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	24 Apr 2021	10,638	27,006 (0%)	0%		0	Common Stock
Raymond Debbane	Director	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	24 Apr 2021	10,638	0	-		-	Restricted Stock Units
Raymond Debbane	Director	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	24 Apr 2021	10,638	327,521 (0%)	0%		0	Common Stock
Samuel L. Barker	Director	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	24 Apr 2021	10,638	0	-		-	Restricted Stock Units
Samuel L. Barker	Director	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	24 Apr 2021	10,638	66,291 (0%)	0%		0	Common Stock
Alan S. Nies	Director	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	24 Apr 2021	10,638	27,720 (0%)	0%		0	Common Stock
Alan S. Nies	Director	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	24 Apr 2021	10,638	0	-		-	Restricted Stock Units
Christopher J. Sobecki	Director	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	24 Apr 2021	10,638	0	-		-	Restricted Stock Units
Christopher J. Sobecki	Director	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	24 Apr 2021	10,638	151,397 (0%)	0%		0	Common Stock
Philippe J. Amouyal	Director	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	24 Apr 2021	10,638	0	-		-	Restricted Stock Units
Philippe J. Amouyal	Director	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	24 Apr 2021	10,638	27,006 (0%)	0%		0	Common Stock
Judith L. Swain	Director	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	24 Apr 2021	10,638	27,006 (0%)	0%		0	Common Stock
Judith L. Swain	Director	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	24 Apr 2021	10,638	0	-		-	Restricted Stock Units
Robert J. Lefkowitz	Director	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	24 Apr 2021	10,638	0	-		-	Restricted Stock Units
Robert J. Lefkowitz	Director	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	24 Apr 2021	10,638	27,006 (0%)	0%		0	Common Stock
James F. Tessmer	VP, Finance & Accounting	Sale of securities on an exchange or to another person at price $ 6.92 per share.	15 Mar 2021	12,000	71,766 (0%)	0%	6.9	83,100	Common Stock
James F. Tessmer	VP, Finance & Accounting	Sale of securities on an exchange or to another person at price $ 6.90 per share.	15 Mar 2021	10,912	71,766 (0%)	0%	6.9	75,340	Common Stock
James F. Tessmer	VP, Finance & Accounting	Exercise or conversion of derivative security received from the company (such as an option) at price $ 3.31 per share.	15 Mar 2021	12,000	83,766 (0%)	0%	3.3	39,720	Common Stock
James F. Tessmer	VP, Finance & Accounting	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	15 Mar 2021	12,000	50,980	-		-	Stock Option (Right to Buy)
Alan J. Main	EVP, Innov & Chem Sciences		28 Feb 2021	23,300	46,600	-		-	Restricted Stock Units
Alan J. Main	EVP, Innov & Chem Sciences		28 Feb 2021	2,497	107,137 (0%)	0%		-	Common Stock

*All Values are in $ Million

Client Category: Promoter/ KMP/ Director / Immediate Relatives / Employee / etc
Security Type: Share/ Warrants / Convertible Debentures

Data as reported to USA Exchanges

View All The Insider Trades disclosures

213.73% Gain from 52W Low

Insider Trading disclosures for Lexicon Pharma Inc

The latest disclosure was made by Raymond Debbane in Lexicon Pharma Inc where a trade of 35,714 Restricted Stock Units done was reported to US exchanges on May 1, 2026.

Screeners based on Insider Trading and SAST parameters